Alastair Clemow

Alastair John Tanton Clemow was the founder of Nexgen Spine, Inc., founded in 2004, where the title held was President & Chief Executive Officer from 2004 to 2009.
Dr. Clemow is the founder of Ensemble Orthopedics, Inc., founded in 2019, holding the title of Chairman since 2019.
Current jobs include Director at SteriLumen, Inc. and Director at First Wave Technologies, Inc. Former jobs include President & Chief Executive Officer at Gelifex, Inc. from 2002 to 2004; President & Chief Executive Officer at Regentis Biomaterials Ltd. from 2010 to 2019; President & Chief Executive Officer at Minimally Invasive Surgical Technologies Institute from 2000 to 2005; Director at HydroCision, Inc. from 2005 to 2010; Director at Vyteris, Inc. from 2011 to 2012; Director at TrueYou.com, Inc. from 2006 to 2007; Director at BioMedical Enterprises, Inc. from 2001 to 2016; Director at Echo Healthcare Acquisition Corp.
from 2006 to 2009; Director at OPKO Biologics Ltd. from 2005 to 2007; Independent Director at Aevi Genomic Medicine, Inc. from 2010 to 2020; Director at Kinetic Muscles, Inc. from 2007 to 2012; Independent Director at Applied UV, Inc. from 2020 to 2022; Vice President-New Business Development at Ethicon Endo-Surgery, Inc. from 1988 to 2000; Vice President-New Business Development at Johnson & Johnson Professional, Inc. from 1981 to 1988; Principal at Tanton Technologies, Inc. from 2000 to 2004; Director-Research & Development at DePuy Orthopaedics, Inc.; Director at DJO Global, Inc.; Director at ReAble Therapeutics, Inc.; Director-Research & Development at Johnson & Johnson Orthopaedics; Director at ECHO Health, Inc.; Director at Encore Medical, Inc. Education includes undergraduate and doctorate degrees from the University of Surrey and an MBA from Columbia Business School.